摘要
Prostate cancer(PCa)initiation,progression,and therapy resistance involve genetic and epigenetic alterations that l e ad to ab err ant cel l line age specification and plasticity.1–3 The vast majority of primary prostate cancers are pathologically defined as luminal cancer with luminal cell expansion and absence of basal cells.
